Abstract
Atopic dermatitis (AD) can have a significantly negative impact on quality of life (QoL). The impact of coronavirus disease 2019 (COVID-19) on the AD population is not yet well established. The study comprised 195 patients with diagnosed AD who were asked about their cognitive and preventive behaviors regarding COVID-19 and the accessibility of medical support, including online consultations. Moreover, the patients responded to the self-reported Dermatology Life Quality Index (DLQI) and Hospital Anxiety and Depression Scale (HADS). Most of the patients were worried about being infected with COVID-19. Most of the patients believed that people suffering from skin disease were more prone to be infected with COVID-19 compared with the general population. Most the patients negatively assessed the availability of dermatological treatment during the pandemic. Furthermore, 66.1% of the patients declared using telemedicine. Nearly 50% of patients were discontented with telemedicine, and 1/3 of the patients did not mind the use of telemedicine. AD during the COVID-19 pandemic was associated with a lower overall health rating and life satisfaction and impaired QoL related to mental health in a Polish population. These results provide original information that can be applied in dermatologic patient screenings to evaluate the state of depression and anxiety during the epidemic period.
Highlights
Accepted: 29 January 2022Atopic dermatitis (AD) is a common, chronic, inflammatory and pruritic disease characterized by eczematous skin lesions, skin pain and sleep disturbances [1]
The patients responded to the self-reported Dermatology Life Quality Index (DLQI) and Hospital Anxiety and Depression Scale (HADS)
No one was asked to quarantine due to suspicion of infection nor had they been infected with COVID-19
Summary
Atopic dermatitis (AD) is a common, chronic, inflammatory and pruritic disease characterized by eczematous skin lesions, skin pain and sleep disturbances [1]. It is a disease of complex etiology. Genetic and environmental factors are involved in the pathogenesis of the disease [2,3,4]. The pathophysiology of AD is involved in dysfunction of the epidermal barrier [5]. The frequency of appearance of AD is 10–20% of children and 1–3%. AD can have a significantly negative impact on the quality of life (QoL), which, in some cases, can lead to social isolation and psychological problems [7]
Sign-in/Register to view highlights & summary 
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call